View Older Stories View More Recent Stories

May 21, 2025 12:49PM Scotiabank Reiterates Sector Perform Rating on Vertex (VRTX)
May 19, 2025 04:27PM Vertex Pharma (VRTX) Approves Additional $4B Buyback Program
May 14, 2025 09:29AM Stifel Reiterates Hold Rating on Vertex (VRTX)
May 7, 2025 07:23AM Bernstein on Vertex (VRTX): 'We'd Sit Tght' Following Yesterday's Stock Sell-Off
May 7, 2025 07:18AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
May 7, 2025 12:07AM Wolfe Research Downgrades Vertex (VRTX) to Peerperform
May 6, 2025 10:50AM Vertex (VRTX) PT Raised to $462 at Bernstein SocGen Group
May 6, 2025 09:59AM Stifel Reiterates Hold Rating on Vertex (VRTX)
May 6, 2025 09:11AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
May 6, 2025 07:08AM Vertex (VRTX) PT Lowered to $442 at Scotiabank
May 6, 2025 06:18AM Leerink Partners Downgrades Vertex (VRTX) to Market Perform 'on Lower Pain Projections'
May 5, 2025 04:45PM After-hours movers: Palantir, Ford, Clorox and more
May 5, 2025 04:04PM Vertex Pharma (VRTX) Misses Q1 EPS by 20c; raises guidance
May 5, 2025 05:33AM Vertex Pharma (VRTX) call put ratio 1.2 calls to 1 put into quarter results
May 2, 2025 11:07AM Vertex Pharma (VRTX) call put ratio 5.8 calls to 1 put into quarter results
Apr 22, 2025 10:56AM UBS Reiterates Buy Rating on Vertex (VRTX)
Apr 22, 2025 08:06AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Apr 22, 2025 07:24AM Cantor Fitzgerald Assumes Vertex (VRTX) at Overweight
Apr 14, 2025 01:55PM BMO Capital on Vertex (VRTX): 'Growth Continues as We Look Ahead to 1Q Earnings'
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 7, 2025 12:01PM Vertex Pharma (VRTX) announces European Commission approval of KAFTRIO label expansion
Apr 1, 2025 08:24AM Vertex (VRTX) PT Raised to $420 at RBC Capital; 'Alyftrek Could Be Off To a Good Start'
Apr 1, 2025 06:40AM Canaccord Genuity Reiterates Hold Rating on Vertex (VRTX)
Mar 28, 2025 04:05PM Vertex Pharma (VRTX) Announces Program Updates for Type 1 Diabetes Portfolio
Mar 17, 2025 08:16AM DA Davidson Reiterates Buy Rating on Vertex (VRTX)
Mar 7, 2025 10:02AM Vertex Pharma (VRTX) Announces UK MHRA Approval of ALYFTREK
Feb 28, 2025 07:22AM Vertex Pharma (VRTX) Receives CHMP Positive Opinion for Expanded Label for KAFTRIO in Combination With Ivacaftor
Feb 20, 2025 08:51AM Vertex (VRTX) PT Raised to $408 at RBC Capital
Feb 18, 2025 10:13AM DA Davidson Reiterates Buy Rating on Vertex (VRTX)
Feb 11, 2025 08:37AM TD Cowen Reiterates Buy Rating on Vertex (VRTX): 'VRTX is a Top 2025 L.C. Biotech Pick'
Feb 11, 2025 08:03AM Vertex (VRTX) PT Raised to $520 at Truist on 'Incrementally Positive Commercial Outlook'
Feb 11, 2025 07:10AM Vertex (VRTX) PT Raised to $459 at Morgan Stanley
Feb 11, 2025 07:09AM BMO Capital Expects '2 New Launches to Drive 2025 PnL' for Vertex (VRTX)
Feb 11, 2025 06:53AM Vertex (VRTX) PT Raised to $450 at Scotiabank
Feb 11, 2025 06:50AM Piper Sandler: 'Vertex (VRTX) Firing on All Cylinders'
Feb 11, 2025 06:39AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Feb 11, 2025 05:44AM Vertex (VRTX) PT Raised to $444 at Bernstein After Journavx and Alyftrek Launches
Feb 10, 2025 04:04PM Vertex Pharma (VRTX) Misses Q4 EPS by 4c, Revenues Beat
Feb 7, 2025 10:26AM Vertex Pharma (VRTX) call put ratio 5.1 calls to 1 put with a focus on February 14 weekly calls into quarter results
Feb 7, 2025 05:03AM Vertex Pharma (VRTX) call put ratio 2.8 calls to 1 put into quarter results
Feb 3, 2025 06:35AM Vertex (VRTX) PT Raised to $550 at H.C. Wainwright
Jan 31, 2025 08:44AM Vertex (VRTX) PT Raised to $545 at BMO Capital Following Suzetrigine's approval
Jan 31, 2025 07:34AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Jan 30, 2025 06:26PM Vertex Pharma (VRTX) announces FDA Approval of JOURNAVX
Jan 30, 2025 05:51PM FDA Approves Vertex's (VRTX) Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
Jan 27, 2025 07:50AM Vertex (VRTX) PT Lowered to $533 at Piper Sandler on Adjusted Q424 Casgevy Revenue Estimates
Jan 24, 2025 07:33AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 10, 2025 07:32AM Zai Lab (ZLAB) and Vertex (VRTX) Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
Jan 7, 2025 09:15AM Vertex (VRTX) PT Raised to $401 at RBC Capital; 'We Would Look for a More Compelling Entry Point'
View More Recent Stories View Older Stories